Myositis in a Patient with Advanced Lung Cancer Treated with Osimertinib

被引：8
|
作者：
Fujioka, Shusei [1 ]
Kitajima, Takamasa [1 ]
Itotani, Ryo [1 ]
机构：
[1] Kitano Hosp, Tazuke Kofukai Med Res Inst, Resp Dis Ctr, Div Resp Med, Osaka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 08期
关键词：
D O I：
10.1016/j.jtho.2018.03.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E137 / E139
页数：4
相关论文
共 50 条
  • [1] Rhabdomyolysis in a patient with advanced lung cancer treated with osimertinib: a case report
    Li, You
    Liu, Yu
    Zhao, Zichen
    Zhang, Yan
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (03) : 629 - 636
  • [2] NICE approves osimertinib for advanced lung cancer
    Burki, Talha Khan
    LANCET RESPIRATORY MEDICINE, 2016, 4 (12): : 954 - 954
  • [3] Early-onset interstitial pneumonitis in a patient with advanced non-small cell lung cancer treated with crizotinib and osimertinib
    Cheng, Yuan
    Yu, Qing
    Xiong, Yan
    Guo, Cuiyan
    Nie, Ligong
    THORACIC CANCER, 2021, 12 (05) : 690 - 692
  • [4] Efficacy and Safety of Osimertinib in a Hemodialysis Patient With Advanced Non-Small Cell Lung Cancer
    Iwafuchi, Yoichi
    Saito, Isao
    Narita, Ichiei
    THERAPEUTIC APHERESIS AND DIALYSIS, 2017, 21 (04) : 416 - 417
  • [5] Patient Experience of Symptoms and Side Effects when Treated with Osimertinib for Advanced Non-Small-Cell Lung Cancer: A Qualitative Interview Substudy
    Ryden, Anna
    Blackhall, Fiona
    Kim, Hye Ryun
    Pillai, Rathi N.
    Braam, Lauren
    Martin, Mona L.
    Walding, Andrew
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2017, 10 (05): : 593 - 603
  • [6] Patient Experience of Symptoms and Side Effects when Treated with Osimertinib for Advanced Non-Small-Cell Lung Cancer: A Qualitative Interview Substudy
    Anna Rydén
    Fiona Blackhall
    Hye Ryun Kim
    Rathi N. Pillai
    Lauren Braam
    Mona L. Martin
    Andrew Walding
    The Patient - Patient-Centered Outcomes Research, 2017, 10 : 593 - 603
  • [7] Acquired resistance to osimertinib in advanced lung cancer: A case report
    Xu, Jiayi
    Xu, Zikai
    Hong, Jianwei
    Zhou, Xiaoyu
    ASIAN JOURNAL OF SURGERY, 2024, 47 (08) : 3763 - 3764
  • [8] Occurrence of Ventricular Fibrillation in a Patient With Lung Cancer Receiving Osimertinib
    Kaira, Kyoichi
    Ogiwara, Yasufumi
    Naruse, Ichiro
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (04) : E54 - E55
  • [9] Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab
    Mamesaya, Nobuaki
    Kenmotsu, Hirotsugu
    Takahashi, Toshiaki
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (06) : 839 - 841
  • [10] Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab
    Nobuaki Mamesaya
    Hirotsugu Kenmotsu
    Toshiaki Takahashi
    Investigational New Drugs, 2017, 35 : 839 - 841
12345